Emmaus Life Sciences, Inc. (EMMA)
About Emmaus Life Sciences, Inc.
EMMAUS LIFE SCIENCES INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $12.5M
- Net income
- -$7.5M
- Total assets
- $21.4M
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Emmaus Life Sciences, Inc. (EMMA) Stock Price
- Reported a net loss of $7.5M in FY2025.
- Trading 50% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Emmaus Life Sciences, Inc..
Write a review
News about Emmaus Life Sciences, Inc.
News & sentiment via Polygon.io
Emmaus Life Sciences, Inc.: frequently asked questions
Is Emmaus Life Sciences, Inc. an American company?
Emmaus Life Sciences, Inc. is a US-based company headquartered in Torrance, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Emmaus Life Sciences, Inc. headquartered?
Emmaus Life Sciences, Inc. is headquartered in Torrance, California, United States.
Is Emmaus Life Sciences, Inc. publicly traded?
Yes — Emmaus Life Sciences, Inc. is a publicly traded company. Its stock trades under the ticker symbol EMMA on the OTC.
What does Emmaus Life Sciences, Inc. do?
Emmaus Life Sciences, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
